Search: onr:"swepub:oai:research.chalmers.se:ea7ad3fd-772c-43e2-aed8-c528e053e9f4" > A Novel Method for ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03653naa a2200385 4500 | |
001 | oai:research.chalmers.se:ea7ad3fd-772c-43e2-aed8-c528e053e9f4 | |
003 | SwePub | |
008 | 220225s2021 | |||||||||||000 ||eng| | |
024 | 7 | a https://research.chalmers.se/publication/5288282 URI |
024 | 7 | a https://doi.org/10.1109/EMBC46164.2021.96296782 DOI |
040 | a (SwePub)cth | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a kon2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Visentin, Robertou Università Degli Studi di Padova,University of Padua4 aut |
245 | 1 0 | a A Novel Method for Generation of in Silico Subjects with Type 2 Diabetes |
264 | 1 | c 2021 |
520 | a A type 2 diabetes (T2D) simulator has been recently proposed for supporting drug development and treatment optimization. This tool consists of a physiological model of glucose/insulin/C-peptide dynamics and a virtual cohort of T2D subjects (i.e., random extractions of model parameterizations from a joint parameter distribution) well describing both average and variability realistic T2D dynamics. However, the state-of-art procedure to get a reliable virtual population requires some post-processing after subject extraction, in order to discard implausible behaviors. We propose an improved method for virtual subjects' generation to overcome this burdensome task. To do so, we first assessed a refined joint parameter distribution, from which extracting a number of subjects, greater than the target population size. Then, target-size subsets are undersampled from the large cohort. The final virtual population is selected among the subsets as the one maximizing the similarity with T2D data and model parameter distribution, by means of measurement' outcome metrics and Euclidian distance (Δ), respectively. In the final population, almost all the outcome metrics are statistically identical to the clinical counterparts (p-value>0.05) and model parameters' distribution differs by ~5-10% from that derived from data. The methodology described here is flexible, thus resulting suitable for different T2D stages and type 1 diabetes, as well.Clinical Relevance - A straightforward subjects' generation would ease the availability of tailored in silico trials for testing diabetes treatment in a specific population. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Farmaceutiska vetenskaper0 (SwePub)301012 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Pharmaceutical Sciences0 (SwePub)301012 hsv//eng |
650 | 7 | a NATURVETENSKAPx Data- och informationsvetenskapx Bioinformatik0 (SwePub)102032 hsv//swe |
650 | 7 | a NATURAL SCIENCESx Computer and Information Sciencesx Bioinformatics0 (SwePub)102032 hsv//eng |
650 | 7 | a NATURVETENSKAPx Matematikx Sannolikhetsteori och statistik0 (SwePub)101062 hsv//swe |
650 | 7 | a NATURAL SCIENCESx Mathematicsx Probability Theory and Statistics0 (SwePub)101062 hsv//eng |
653 | a Diabetes Mellitus, Type 2 | |
653 | a Blood Glucose | |
653 | a Insulin | |
653 | a Humans | |
653 | a Diabetes Mellitus, Type 1 | |
700 | 1 | a de Lazzari, Mattia,d 1996u Chalmers tekniska högskola,Chalmers University of Technology4 aut0 (Swepub:cth)lazzari |
710 | 2 | a Università Degli Studi di Padovab Chalmers tekniska högskola4 org |
773 | 0 | t Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBSg , s. 1380-1383q <1380-1383x 1557-170X |
856 | 4 8 | u https://research.chalmers.se/publication/528828 |
856 | 4 8 | u https://doi.org/10.1109/EMBC46164.2021.9629678 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Copy and save the link in order to return to this view